The mRNA vaccines and therapeutics market is expected to experience growth, with various reports forecasting its size and share by 2034. Estimates of the market's value by 2034 range from approximately $41 billion to nearly $298 billion by 2035, indicating some uncertainty in the projections. The market's expansion is likely driven by increasing applications in healthcare.